A SIN lentiviral vector containing piga cdna allows long-term phenotypic correction of CD34+-derived cells from patients with paroxysmal nocturnal hemoglobinuria
Authors:
Open Access
- 31 March 2003
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 7 (3) , 304-316
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Risks and Benefits of Gene Therapy for Immunodeficiency: a Reality CheckGene Therapy, 2002
- Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: risk of insertional mutagenesisBlood, 2002
- Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative ConditioningScience, 2002
- Gene Therapy of a Mouse Model of Protoporphyria with a Self-Inactivating Erythroid-Specific Lentiviral Vector without PreselectionMolecular Therapy, 2001
- Efficient retrovirus-mediated PIG-A gene transfer and stable restoration of GPI-anchored protein expression in cells with the PNH phenotypeBlood, 2001
- Correction of Deficient CD34+ Cells from Peripheral Blood after Mobilization in a Patient with Congenital Erythropoietic PorphyriaMolecular Therapy, 2001
- Lentiviral Vectors for Enhanced Gene Expression in Human Hematopoietic CellsMolecular Therapy, 2000
- Bone marrow transplantation for paroxysmal nocturnal haemoglobinuriaBritish Journal of Haematology, 1999
- Bone marrow transplants for paroxysmal nocturnal haemoglobinuriaBritish Journal of Haematology, 1999
- Successful autologous transplantation in a patient with severe aplastic anemia (SAA)Bone Marrow Transplantation, 1998